Exact Mass: 556.1217

Exact Mass Matches: 556.1217

Found 20 metabolites which its exact mass value is equals to given mass value 556.1217, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Salvianolic acid K

2-{4-[(1E)-3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-2-hydroxyphenoxy}-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

C27H24O13 (556.1217)


Salvianolic acid K, also known as salvianolate K, is a member of the class of compounds known as lignans, neolignans and related compounds. Lignans, neolignans and related compounds are plant products of low molecular weight formed primarily from oxidative coupling of two p-propylphenol moieties. They can also be described as micromolecules with two phenylpropanoid units coupled together. They can be attached in various manners, like C5-C5, C8-C8. Most known natural lignans are oxidized at C9 and C9¬¥ and, based upon the way in which oxygen is incorporated into the skeleton and on the cyclization patterns, a wide range of lignans of very different structural types can be formed. Salvianolic acid K is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Salvianolic acid K can be found in common sage, which makes salvianolic acid K a potential biomarker for the consumption of this food product. Salvianolic acid K, also known as salvianolate K, is a member of the class of compounds known as lignans, neolignans and related compounds. Lignans, neolignans and related compounds are plant products of low molecular weight formed primarily from oxidative coupling of two p-propylphenol moieties. They can also be described as micromolecules with two phenylpropanoid units coupled together. They can be attached in various manners, like C5-C5, C8-C8. Most known natural lignans are oxidized at C9 and C9´ and, based upon the way in which oxygen is incorporated into the skeleton and on the cyclization patterns, a wide range of lignans of very different structural types can be formed. Salvianolic acid K is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Salvianolic acid K can be found in common sage, which makes salvianolic acid K a potential biomarker for the consumption of this food product.

   

debromooxysceptrin acetate

debromooxysceptrin acetate

C22H25BrN10O3 (556.1294)


   

salvianolic acid K

salvianolic acid K

C27H24O13 (556.1217)


   

2S-2-(4-hydroxyphenyl)-9,10,11-trihydroxy-2H-benzo[c]furo[2,3-f ]-chromen-7(3H)-one-4-O-beta-D-glucopyranoside|polygonumoside A

2S-2-(4-hydroxyphenyl)-9,10,11-trihydroxy-2H-benzo[c]furo[2,3-f ]-chromen-7(3H)-one-4-O-beta-D-glucopyranoside|polygonumoside A

C27H24O13 (556.1217)


   

6-O-[(6-O-malonyl)-beta-D-glucopyranosyl]-5-hydroxy-7-(4-hydroxyphenyl)-3H-benzo[de]isochromen-1-one

6-O-[(6-O-malonyl)-beta-D-glucopyranosyl]-5-hydroxy-7-(4-hydroxyphenyl)-3H-benzo[de]isochromen-1-one

C27H24O13 (556.1217)


   

5-(4-(Bromomethyl)-[1,1-biphenyl]-2-yl)-1-trityl-1H-tetrazole

5-(4-(Bromomethyl)-[1,1-biphenyl]-2-yl)-1-trityl-1H-tetrazole

C33H25BrN4 (556.1262)


   

5-[2-[4-(bromomethyl)phenyl]phenyl]-2-trityltetrazole

5-[2-[4-(bromomethyl)phenyl]phenyl]-2-trityltetrazole

C33H25BrN4 (556.1262)


   

3-(triphenylphosphonio)propane-1-sulfoni

3-(triphenylphosphonio)propane-1-sulfoni

C28H29O6PS2 (556.1143)


   

Sulfo-NHS-LC-Biotin sodium

Sulfo-NHS-LC-Biotin sodium

C20H29N4NaO9S2 (556.1274)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,4-dichlorophenyl)methyl]acetamide

C25H30Cl2N2O6S (556.1202)


   

4-bromo-n-{[(1r,2s,3s,4r)-2-[(4r)-5-hydroxy-2-imino-3,4-dihydroimidazol-4-yl]-3-(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-1h-pyrrole-2-carboxamide

4-bromo-n-{[(1r,2s,3s,4r)-2-[(4r)-5-hydroxy-2-imino-3,4-dihydroimidazol-4-yl]-3-(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-1h-pyrrole-2-carboxamide

C22H25BrN10O3 (556.1294)


   

4-bromo-n-{[2-(5-hydroxy-2-imino-3,4-dihydroimidazol-4-yl)-3-(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-1h-pyrrole-2-carboxamide

4-bromo-n-{[2-(5-hydroxy-2-imino-3,4-dihydroimidazol-4-yl)-3-(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-1h-pyrrole-2-carboxamide

C22H25BrN10O3 (556.1294)


   

2-[3-(2,4-dihydroxyphenoxy)-4-hydroxyphenyl]-5,7-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-4-one

2-[3-(2,4-dihydroxyphenoxy)-4-hydroxyphenyl]-5,7-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-4-one

C27H24O13 (556.1217)


   

(15r)-3,4,5-trihydroxy-15-(4-hydroxyphenyl)-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9,16-dioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),3,5,11,13(17)-hexaen-8-one

(15r)-3,4,5-trihydroxy-15-(4-hydroxyphenyl)-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9,16-dioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),3,5,11,13(17)-hexaen-8-one

C27H24O13 (556.1217)


   

2-(4-{3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl}-2-hydroxyphenoxy)-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

2-(4-{3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl}-2-hydroxyphenoxy)-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

C27H24O13 (556.1217)


   

2-[3-(2,4-dihydroxyphenoxy)-4-hydroxyphenyl]-5,7-dihydroxy-3-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

2-[3-(2,4-dihydroxyphenoxy)-4-hydroxyphenyl]-5,7-dihydroxy-3-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one

C27H24O13 (556.1217)


   

(2r,3r)-2-{4-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-2-hydroxyphenoxy}-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

(2r,3r)-2-{4-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-2-hydroxyphenoxy}-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

C27H24O13 (556.1217)


   

(2r,3s)-2-{4-[(1e)-3-[(1s)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-2-hydroxyphenoxy}-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

(2r,3s)-2-{4-[(1e)-3-[(1s)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-2-hydroxyphenoxy}-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid

C27H24O13 (556.1217)


   

(15s)-3,4,5-trihydroxy-15-(4-hydroxyphenyl)-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9,16-dioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),3,5,11,13(17)-hexaen-8-one

(15s)-3,4,5-trihydroxy-15-(4-hydroxyphenyl)-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9,16-dioxatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-1(10),2(7),3,5,11,13(17)-hexaen-8-one

C27H24O13 (556.1217)